Ketamine in COVID-19 patients: Thinking out of the box
J Med Virol
.
2021 Jul;93(7):4069-4070.
doi: 10.1002/jmv.26681.
Epub 2020 Dec 1.
Authors
Karolina Akinosoglou
1
,
Athanasios Gogos
2
,
Charalambos Papageorgiou
2
,
Elias Angelopoulos
2
,
Charalambos Gogos
1
Affiliations
1
Department of Internal Medicine and Infectious Diseases, University of Patras, Patras, Greece.
2
Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
PMID:
33215721
PMCID:
PMC7753268
DOI:
10.1002/jmv.26681
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / immunology
COVID-19 / psychology*
COVID-19 Drug Treatment*
Humans
Ketamine / therapeutic use*
Mental Disorders / drug therapy*
Substances
Ketamine